Artificial Intelligence (AI) In Drug Discovery Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. End User Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) In Drug Discovery Market 

5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Drug Discovery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence (AI) In Drug Discovery Market, By Type

8.1. Artificial Intelligence (AI) In Drug Discovery Market, by Type, 2024-2033

8.1.1. Preclinical and Clinical Testing

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Molecule Screening

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Target Identification

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. De Novo Drug Design and Drug Optimization

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Artificial Intelligence (AI) In Drug Discovery Market, By Application

9.1. Artificial Intelligence (AI) In Drug Discovery Market, by Application, 2024-2033

9.1.1. Neurology

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Infectious Disease

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Oncology

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Artificial Intelligence (AI) In Drug Discovery Market, By Drug Type

10.1. Artificial Intelligence (AI) In Drug Discovery Market, by Drug Type, 2024-2033

10.1.1. Small Molecules

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Large Molecules

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Artificial Intelligence (AI) In Drug Discovery Market, By Offering

11.1. Artificial Intelligence (AI) In Drug Discovery Market, by Offering, 2024-2033

11.1.1. Software

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Services

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Artificial Intelligence (AI) In Drug Discovery Market, By Technology

12.1. Artificial Intelligence (AI) In Drug Discovery Market, by Technology, 2024-2033

12.1.1. Machine Learning

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Other Technologies

12.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Artificial Intelligence (AI) In Drug Discovery Market, By End User

13.1. Artificial Intelligence (AI) In Drug Discovery Market, by End User, 2024-2033

13.1.1. Pharmaceutical & Biotechnology Companies

13.1.1.1. Market Revenue and Forecast (2021-2033)

13.1.2. Contract Research Organizations

13.1.2.1. Market Revenue and Forecast (2021-2033)

13.1.3. Academics & Research

13.1.3.1. Market Revenue and Forecast (2021-2033)

13.1.4. Others

13.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 14. Global Artificial Intelligence (AI) In Drug Discovery Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Type (2021-2033)

14.1.2. Market Revenue and Forecast, by Application (2021-2033)

14.1.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.1.4. Market Revenue and Forecast, by Offering (2021-2033)

14.1.5. Market Revenue and Forecast, by Technology (2021-2033)

14.1.6. Market Revenue and Forecast, by End User (2021-2033)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Type (2021-2033)

14.1.7.2. Market Revenue and Forecast, by Application (2021-2033)

14.1.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.1.7.4. Market Revenue and Forecast, by Offering (2021-2033)

14.1.8. Market Revenue and Forecast, by Technology (2021-2033)

14.1.8.1. Market Revenue and Forecast, by End User (2021-2033) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Type (2021-2033)

14.1.9.2. Market Revenue and Forecast, by Application (2021-2033)

14.1.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.1.9.4. Market Revenue and Forecast, by Offering (2021-2033)

14.1.10. Market Revenue and Forecast, by Technology (2021-2033)

14.1.11. Market Revenue and Forecast, by End User (2021-2033)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Type (2021-2033)

14.2.2. Market Revenue and Forecast, by Application (2021-2033)

14.2.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.2.4. Market Revenue and Forecast, by Offering (2021-2033) 

14.2.5. Market Revenue and Forecast, by Technology (2021-2033)

14.2.6. Market Revenue and Forecast, by End User (2021-2033)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Type (2021-2033)

14.2.8.2. Market Revenue and Forecast, by Application (2021-2033)

14.2.8.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.2.9. Market Revenue and Forecast, by Offering (2021-2033) 

14.2.10. Market Revenue and Forecast, by Technology (2021-2033)

14.2.10.1. Market Revenue and Forecast, by End User (2021-2033) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Type (2021-2033)

14.2.11.2. Market Revenue and Forecast, by Application (2021-2033)

14.2.11.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.2.12. Market Revenue and Forecast, by Offering (2021-2033)

14.2.13. Market Revenue and Forecast, by Technology (2021-2033)

14.2.14. Market Revenue and Forecast, by End User (2021-2033)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Type (2021-2033)

14.2.15.2. Market Revenue and Forecast, by Application (2021-2033)

14.2.15.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.2.15.4. Market Revenue and Forecast, by Offering (2021-2033)

14.2.16. Market Revenue and Forecast, by Technology (2021-2033)

14.2.16.1. Market Revenue and Forecast, by End User (2021-2033)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Type (2021-2033)

14.2.17.2. Market Revenue and Forecast, by Application (2021-2033)

14.2.17.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.2.17.4. Market Revenue and Forecast, by Offering (2021-2033)

14.2.18. Market Revenue and Forecast, by Technology (2021-2033)

14.2.18.1. Market Revenue and Forecast, by End User (2021-2033)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Type (2021-2033)

14.3.2. Market Revenue and Forecast, by Application (2021-2033)

14.3.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.3.4. Market Revenue and Forecast, by Offering (2021-2033)

14.3.5. Market Revenue and Forecast, by Technology (2021-2033)

14.3.6. Market Revenue and Forecast, by End User (2021-2033)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

14.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

14.3.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.3.7.4. Market Revenue and Forecast, by Offering (2021-2033)

14.3.8. Market Revenue and Forecast, by Technology (2021-2033)

14.3.9. Market Revenue and Forecast, by End User (2021-2033)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Type (2021-2033)

14.3.10.2. Market Revenue and Forecast, by Application (2021-2033)

14.3.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.3.10.4. Market Revenue and Forecast, by Offering (2021-2033)

14.3.11. Market Revenue and Forecast, by Technology (2021-2033)

14.3.11.1. Market Revenue and Forecast, by End User (2021-2033)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Type (2021-2033)

14.3.12.2. Market Revenue and Forecast, by Application (2021-2033)

14.3.12.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.3.12.4. Market Revenue and Forecast, by Offering (2021-2033)

14.3.12.5. Market Revenue and Forecast, by Technology (2021-2033)

14.3.12.6. Market Revenue and Forecast, by End User (2021-2033)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Type (2021-2033)

14.3.13.2. Market Revenue and Forecast, by Application (2021-2033)

14.3.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.3.13.4. Market Revenue and Forecast, by Offering (2021-2033)

14.3.13.5. Market Revenue and Forecast, by Technology (2021-2033)

14.3.13.6. Market Revenue and Forecast, by End User (2021-2033)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Type (2021-2033)

14.4.2. Market Revenue and Forecast, by Application (2021-2033)

14.4.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.4.4. Market Revenue and Forecast, by Offering (2021-2033)

14.4.5. Market Revenue and Forecast, by Technology (2021-2033)

14.4.6. Market Revenue and Forecast, by End User (2021-2033)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

14.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

14.4.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.4.7.4. Market Revenue and Forecast, by Offering (2021-2033)

14.4.8. Market Revenue and Forecast, by Technology (2021-2033)

14.4.9. Market Revenue and Forecast, by End User (2021-2033)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Type (2021-2033)

14.4.10.2. Market Revenue and Forecast, by Application (2021-2033)

14.4.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.4.10.4. Market Revenue and Forecast, by Offering (2021-2033)

14.4.11. Market Revenue and Forecast, by Technology (2021-2033)

14.4.12. Market Revenue and Forecast, by End User (2021-2033)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Type (2021-2033)

14.4.13.2. Market Revenue and Forecast, by Application (2021-2033)

14.4.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.4.13.4. Market Revenue and Forecast, by Offering (2021-2033)

14.4.13.5. Market Revenue and Forecast, by Technology (2021-2033)

14.4.13.6. Market Revenue and Forecast, by End User (2021-2033)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Type (2021-2033)

14.4.14.2. Market Revenue and Forecast, by Application (2021-2033)

14.4.14.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.4.14.4. Market Revenue and Forecast, by Offering (2021-2033)

14.4.14.5. Market Revenue and Forecast, by Technology (2021-2033)

14.4.14.6. Market Revenue and Forecast, by End User (2021-2033)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Type (2021-2033)

14.5.2. Market Revenue and Forecast, by Application (2021-2033)

14.5.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.5.4. Market Revenue and Forecast, by Offering (2021-2033)

14.5.5. Market Revenue and Forecast, by Technology (2021-2033)

14.5.6. Market Revenue and Forecast, by End User (2021-2033)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Type (2021-2033)

14.5.7.2. Market Revenue and Forecast, by Application (2021-2033)

14.5.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.5.7.4. Market Revenue and Forecast, by Offering (2021-2033)

14.5.8. Market Revenue and Forecast, by Technology (2021-2033)

14.5.8.1. Market Revenue and Forecast, by End User (2021-2033)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Type (2021-2033)

14.5.9.2. Market Revenue and Forecast, by Application (2021-2033)

14.5.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)

14.5.9.4. Market Revenue and Forecast, by Offering (2021-2033)

14.5.9.5. Market Revenue and Forecast, by Technology (2021-2033)

14.5.9.6. Market Revenue and Forecast, by End User (2021-2033)

Chapter 15. Company Profiles

15.1. NVIDIA CORPORATION

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Microsoft Corporation

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. INSILICO MEDICINE INC.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Schrödinger

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. EXSCIENTIA

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Cloud Pharmaceuticals

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. TOMWISE, INC

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms